Recombinant multi-species MAT1A/MAT2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAT1A/MAT2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene catalyzes a two-step reaction that involves the transfer of the adenosyl moiety of ATP to methionine to form S-adenosylmethionine and tripolyphosphate, which is subsequently cleaved to PPi and Pi. S-adenosylmethionine is the source of methyl groups for most biological methylations. The encoded protein is found as a homotetramer (MAT I) or a homodimer (MAT III) whereas a third form, MAT II (gamma), is encoded by the MAT2A gene. Mutations in this gene are associated with methionine adenosyltransferase deficiency. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AdoMet,AdoMet synthase 1,Ams,MAT,MAT1A,MAT2A,MATA1,Mat1a,Methionine adenosyltransferase 1 (MAT 1),Methionine adenosyltransferase I/III (MAT-I/III),S-adenosylmethionine synthase isoform type-1,SADE,SAMS,SAMS1,SAS

Target products collectionGo to MAT1A/MAT2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8799-Ag-1/ GM-Tg-hg-IP8799-Ag-2 Human MAT1A/MAT2A protein Human
GM-Tg-rg-IP8799-Ag-1/ GM-Tg-rg-IP8799-Ag-2 Rat MAT1A/MAT2A protein Rat
GM-Tg-mg-IP8799-Ag-1/ GM-Tg-mg-IP8799-Ag-2 Mouse MAT1A/MAT2A protein Mouse
GM-Tg-cynog-IP8799-Ag-1/ GM-Tg-cynog-IP8799-Ag-2 Cynomolgus/Rhesus macaque MAT1A/MAT2A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8799-Ag-1/ GM-Tg-felg-IP8799-Ag-2 Feline MAT1A/MAT2A protein Feline
GM-Tg-cang-IP8799-Ag-1/ GM-Tg-cang-IP8799-Ag-2 Canine MAT1A/MAT2A protein Canine
GM-Tg-bovg-IP8799-Ag-1/ GM-Tg-bovg-IP8799-Ag-2 Bovine MAT1A/MAT2A protein Bovine
GM-Tg-equg-IP8799-Ag-1/ GM-Tg-equg-IP8799-Ag-2 Equine MAT1A/MAT2A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8799-Ag-1/ GM-Tg-hg-IP8799-Ag-2; GM-Tg-rg-IP8799-Ag-1/ GM-Tg-rg-IP8799-Ag-2;
GM-Tg-mg-IP8799-Ag-1/ GM-Tg-mg-IP8799-Ag-2; GM-Tg-cynog-IP8799-Ag-1/ GM-Tg-cynog-IP8799-Ag-2;
GM-Tg-felg-IP8799-Ag-1/ GM-Tg-felg-IP8799-Ag-2; GM-Tg-cang-IP8799-Ag-1/ GM-Tg-cang-IP8799-Ag-2;
GM-Tg-bovg-IP8799-Ag-1/ GM-Tg-bovg-IP8799-Ag-2; GM-Tg-equg-IP8799-Ag-1/ GM-Tg-equg-IP8799-Ag-2
Products Name MAT1A/MAT2A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MAT1A/MAT2A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAT1A/MAT2A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.